Compared with patients with steatosis alone (NAFL), patients with NASH have a significantly increased level of apoptosis [12], as well as pyroptosis with elevated expression of caspase-1 [159] and necroptosis with increased expression of RIP3 [58]. The gene discussed is RIPK3; the disease is metabolic dysfunction-associated steatohepatitis.